Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors "A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome".
作者信息
Spain Lavinia, Larkin James, Martin-Liberal Juan
机构信息
Melanoma Unit, Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.
Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
出版信息
Cancer Immunol Immunother. 2016 Jun;65(6):769-70. doi: 10.1007/s00262-016-1845-2. Epub 2016 May 19.
Abstract
摘要
相似文献
1
Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors "A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome".
Cancer Immunol Immunother. 2016 Jun;65(6):769-70. doi: 10.1007/s00262-016-1845-2. Epub 2016 May 19.
2
A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome.
Cancer Immunol Immunother. 2016 Jun;65(6):765-7. doi: 10.1007/s00262-016-1835-4. Epub 2016 Apr 11.
3
Nivolumab-induced diabetes mellitus-a case report with literature review of the treatment options.
Front Immunol. 2023 Oct 26;14:1248919. doi: 10.3389/fimmu.2023.1248919. eCollection 2023.
4
The application of the insulins in the treatment of diabetes mellitus.
J Lancet. 1950 Oct;70(10):386-8.
5
[Immune Checkpoint Inhibitors Related Diabetes Mellitus:
A Report of 2 Cases and Literature Review].
Zhongguo Fei Ai Za Zhi. 2022 Jan 20;25(1):61-65. doi: 10.3779/j.issn.1009-3419.2021.102.54.
6
Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: a case report and review of the literature.
J Med Case Rep. 2024 Jan 22;18(1):51. doi: 10.1186/s13256-023-04248-7.
7
Biosimilar vs originator insulins: Systematic review and meta-analysis.
Diabetes Obes Metab. 2018 Jul;20(7):1787-1792. doi: 10.1111/dom.13291. Epub 2018 Apr 17.
8
Outpatient use of intermediate- and short-acting semisynthetic human insulins.
Arch Intern Med. 1983 Mar;143(3):465-6.
9
[Chronic insulin urticaria. Therapeutic efficacy and good tolerability of human insulins].
Nouv Presse Med. 1982 Oct 23;11(42):3121-4.
10
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.
Lancet Oncol. 2017 Sep;18(9):1202-1210. doi: 10.1016/S1470-2045(17)30428-X. Epub 2017 Jul 17.
引用本文的文献
1
Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.
Immunotargets Ther. 2017 Oct 10;6:73-82. doi: 10.2147/ITT.S126227. eCollection 2017.
2
Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma.
BMJ Case Rep. 2016 Nov 23;2016:bcr2016217454. doi: 10.1136/bcr-2016-217454.
3
A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.
Cancer Immunol Immunother. 2017 Jan;66(1):25-32. doi: 10.1007/s00262-016-1913-7. Epub 2016 Oct 19.
本文引用的文献
1
A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome.
Cancer Immunol Immunother. 2016 Jun;65(6):765-7. doi: 10.1007/s00262-016-1835-4. Epub 2016 Apr 11.
2
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.
Nat Commun. 2016 Feb 2;7:10391. doi: 10.1038/ncomms10391.
3
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report.
Cancer Immunol Immunother. 2015 Jun;64(6):765-7. doi: 10.1007/s00262-015-1689-1. Epub 2015 Apr 1.
4
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18680-5. doi: 10.1073/pnas.0909307106. Epub 2009 Oct 21.
Zotero 插件